Careers

Reports to: Chief Corporate Development Officer

Location: Seattle, WA (Hybrid)

Scope:

Eupraxia Pharmaceuticals is seeking a dynamic and experienced Vice President of Market Development and Commercial Strategy with extensive experience in pre-approval market development operations and strategy, communications, marketing, pricing and market access and launching new products. This individual will be responsible for driving market development, commercial communications, marketing strategies, focusing initially on Phase 3 market development and communications, launch readiness and commercialization in the U.S. for the lead program EP-104GI for Eosinophilic Esophagitis (EoE). As one of the first commercial hires, this position will be integral in Eupraxia’s transition to a commercial stage biotechnology company.

Key Responsibilities:

Strategic Marketing, Pre-Launch Planning

• Develop and own the integrated EoE market development strategy and pre-launch roadmap, with clear milestones tied to Phase 3 readouts, regulatory submission, and launch.
• Build and maintain a quantitative market model covering EoE epidemiology, the diagnosed-and-treated patient funnel, segmentation of the prescriber base, and identification of conversion bottlenecks across the patient journey.
• Commission and translate primary and secondary market research (HCP, patient, payer) into actionable strategy; identify drivers and barriers to diagnosis, treatment initiation, and persistence.
• Maintain ongoing competitive intelligence across approved and emerging EoE therapies; anticipate evolution of the standard of care
• Lead the development of the 3-year strategic commercial plan, ensuring alignment between Clinical, Regulatory, and Medical Affairs to support a successful launch in the US and potentially global markets.
• Effectively communicate core branding, marketing messages and product positioning statements within the organization.

Stakeholder Engagement (KOLs, Patients)

• Identify, map, and develop trusted relationships with national, regional, and emerging KOLs across academic and high-volume community practices, in close coordination with Medical Affairs and clear separation of commercial and medical responsibilities.
• Design and execute commercial advisory boards, market shaping summits, and steering committees to inform positioning, messaging, and unmet need narratives.
• Represent the franchise externally at major scientific congresses (e.g., DDW, ACG,AAAAI) and contribute to the company’s scientific presence.
• Build and steward strategic relationships with EoE patient advocacy organizations, including but not limited to APFED (American Partnership for Eosinophilic Disorders), CURED Foundation, and other relevant groups.

Market Access & Pricing Support

• Collaborate with Market Access vendors, and eventually internal Market Access leadership to support the appropriate Phase 3 strategy and operational planning to ensure optimal PRMA and HEOR conditions for Phase 3 trails, NDA approval and product launch.
• Support the development of the Health Technology Assessment and equivalent dossiers and value decks for payer presentations, ensuring clinical data is translated into economic value.

Communications

• Participate with Medical Affairs in the development and stewardship of the integrated messaging architecture for EP-104GI, including the unbranded disease-state narrative, the scientific communications platform, and — as the asset progresses toward approval — the branded value proposition and core claims hierarchy.
• Define key messages and supporting proof points for each priority audience: gastroenterologists, allergists/immunologists, pediatric subspecialists, patients and caregivers, payers, investors, and internal stakeholders. Ensure messaging is consistent across all external-facing touchpoints and tailored to each audience’s clinical, economic, or experiential lens.
• Write and own copy for materials in which our lead product is described, including the corporate website, R&D day and investor materials, scientific congress booths and symposia content, advisory board pre-reads, KOL engagement decks, pre-launch HCP and patient disease-state education, and internal commercial training materials.
• Partner closely with Corporate Communications and Investor Relations on press releases, scientific data disclosures, and earnings-cycle materials in which the EoE program is referenced, providing commercial and market context that strengthens the external narrative without compromising regulatory boundaries.

Data, Analytics & Competitive Intelligence

• Establish the early commercial analytics function, including forecasting, patient journey mapping. Secure necessary data contracts (claims data, Rx data) necessary to establish early commercial strategies.
• Oversee global product demand forecasts for manufacturing.
• Maintain a deep understanding of the GI/EoE landscape, monitoring competitor data readouts, pricing strategies, and standard-of-care shifts to adapt our commercial tactics in real-time.

Cross-Functional Collaboration

• Responsible for coordinating the activities and resource planning of the global Market Access, Market Research, Patient Advocacy, and Medical groups, as different teams are added, to align to the global strategy and execution of the business plan.
• Partner with R&D, Clinical, Sales, Market Access, and Medical Affairs to convey consistent messaging and commercial goals.

Lifecycle Management

• Oversee end-to-end launch planning, marketing, and promotional strategies for new and existing assets.

Requirements

• Bachelors’ degree in Business, Life Sciences or related field; MBA or PhD is an asset.
  15+ years of commercial experience in the biotech/pharmaceutical industry, with at least 5 years in a leading market development role focused on the UE. Global experience is an asset.
• Role knowledge: Experience in sales and marketing, market strategy, launch planning, market analytics, pricing, re-imbursement and market access (PRMA)
• Demonstrated pre-launch experience for a specialty product, including at least one successful launch
• Industry Knowledge: Understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement environments, and therapeutic areas (e.g., GI, Immunology and/or specialty therapeutics). A proven track record in a launch of a specialty therapeutic. Experience in Gastroenterology (GI), Immunology, or Rare Disease is highly preferred
• Experience with forecast modeling, budget management (P&L), CRM implementation, and vendor management (agencies, data providers)
• Ability to synthesize complex clinical data into a clear commercial narrative, in both written and oral formats
• Familiarity with the Eosinophilic Esophagitis landscape, including the dynamics of endoscopy-based diagnosis and the role of allergist vs. gastroenterologist referral networks, is a significant plus

Additional attributes

• Highly motivated self-starter with strong initiative in identifying operational improvements
• Clear communicator capable of presenting to senior management, and key external stakeholders
• Proactive problem-solver who can troubleshoot equipment issues and safety concerns independently
• Excellent organizational and time management skills to juggle multiple priorities
• Excellent written, organizational, and analytical skills.
• Continuous learner committed to staying current with development in Eupraxia’s strategic areas of interest (GI disease and EoE)
• Strong vendor and supplier relationship management skills
• Able and willing to travel internationally, especially between Canada, the US and Europe.

Salary Range: $250,000 – $325,000 annually

Reports to: Chief Corporate Development Officer

Location: Seattle, WA or Vancouver, BC

Candidates must be able to work in person from either our Seattle or Vancouver office a minimum of two days per week.

Scope:

Eupraxia Pharmaceuticals is seeking a dynamic Director of External Communications with extensive experience within the biotech/pharma space, with specific experience working at a development stage company with a Phase 2/3 product. This position will play a key role generating the external corporate communications strategy to ensure the company’s evolving story is communicated effectively.  This position will work across functional areas including commercial, investor relations, clinical, medical affairs, research and HR. They will be the point person for generating, reviewing and deploying external communication initiatives across various mediums (with subject matter expertise assistance) and responsible for corporate communications across multiple channels and platforms, including press releases, traditional and social media and for ensuring consistency of communications between corporate and communications and communications at scientific conferences.

Key Responsibilities:

Corporate and Brand Messaging

• Develop communication strategies and plans that effectively communicate corporate and product stories to external audiences.
• Partner and coordinate with the executive team and other functional team members in the overall stewardship of the corporate brand, positioning and messaging.
• Own the process of creating and update company’s overarching narrative and message architecture, ensuring consistency across the website, investor materials, social channels, commercial and medical communications.
• Navigate the process of obtaining approval for the Corporate Branding strategy and content by the Executive Team and other key stakeholder

Content Creation

• Develop and draft external communications materials, including corporate website content, press releases, R&D Day and investor materials, working with the appropriate functional subject matter experts. Where materials contain scientific, clinical or medical content, work closely with the CMO and designated Clinical/Medical subject matter experts, who retain accountability for the scientific and medical content and interpretation.
  Investor Relations and Public Relations
• Contribute to the production of press releases, earnings releases, corporate updates, and clinical trial milestone announcements, in close coordination with the CFO, General Counsel, and CEO.
• Prepare briefing materials for quarterly earnings calls, investor conference presentations, and the annual report / MD&A narrative, working with IR counsel and the executive team.
• Develop talking points, Q&A documents across investor, media, and public forums, ensuring message discipline.
• Support the Investor Relations function on positioning materials, including the corporate deck, fact sheet, and website content, ensuring consistent, non-promotional, compliant messaging across all investor touchpoints.
• Coordinate with IR the external messaging calendar around clinical catalysts, ensuring alignment with continuous disclosure obligations and coordination with the company’s disclosure committee.
• Manage corporate social media presence (LinkedIn, X/Twitter) with a consistent voice appropriate for a regulated public company.

Scientific and Medical Communications

• Provide writing and communications support, as requested, for scientific and medical materials including congress materials, advisory board materials, KOL communications, publications and disease-state education. Scientific and medical strategy, content and interpretation remain the responsibility of the Clinical/Medical organization.
• Ensure external communications containing scientific, clinical or medical information are appropriately reviewed and approved by the accountable Clinical/Medical and other relevant functional leaders before external use.
• Maintain working fluency in the disease areas and competitive landscape, drawing on market research and competitive analysis of the competitive and scientific landscape to sharpen external messaging and anticipate questions from analysts and media.

Commercial

• Supporting the commercial function in defining key messages and supporting proof points for each priority audience: gastroenterologists, allergists/immunologists, pediatric subspecialists, patients and caregivers, payers, investors, and internal stakeholders. Ensure messaging is consistent across all external-facing touchpoints and tailored to each audience’s clinical, economic, or experiential lens.

Requirements

• Bachelors’ degree in Life Sciences or related field; additional communications and/or journalism qualifications are an asset.
• 8–10+ years of progressively senior communications, investor relations, or public relations experience, with at least 5 years in biotech, pharma, or life sciences.
• Understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement environments, and therapeutic areas (e.g., GI, Immunology and/or specialty therapeutics).
• Excellent writing and editing skills, and the ability to translate clinical and scientific data into clear, accurate, non-promotional external messaging.
• Experience with developing and executing communication strategies and tactics.
• Demonstrated experience in public-company investor relations and financial communications, including press release drafting, disclosure coordination, and earnings-related materials.
• Working knowledge of Canadian and/or U.S. securities disclosure requirements and familiarity working with a disclosure committee.
• Strong relationship-management skills with analysts, and agency partners; sound judgment under time pressure and during high-stakes or sensitive situations.
• Proven ability to work with and effectively influence leadership teams while operating in a fast-paced, entrepreneurial, decisive/deadline-oriented environment, heavily regulated industry; strong interpersonal skills and ability to work with others in a positive, collaborative manner.
• Excellent planning and organizational skills, with a keen ability to multi-task.
• Ability to travel domestically and internationally.
• Proficient in Microsoft Word, Excel, SharePoint and PowerPoint.
  Additional attributes
• Highly motivated self-starter with strong initiative in identifying operational improvements.
• Clear communicator capable of presenting to senior management, and key external stakeholders.
• Proactive problem-solver who can troubleshoot equipment issues and safety concerns independently.
• Excellent organizational and time management skills to juggle multiple priorities.
• Continuous learner committed to staying current with development in Eupraxia’s strategic areas of interest (GI disease and EoE).

Salary Range: $165,000 – $210,000 annually

Within the posted range, individual pay is determined by job-related skills, relevant experience, education and/or training. Please note that the range details above reflect the base pay only. A bonus will be available based on performance and remaining in post for the agreed contract duration. We also offer a competitive benefits package.

How to Apply:

Please apply at link below. While only short-listed candidates will be notified, we thank each applicant for their submission.

Eupraxia Pharmaceuticals is an equal opportunity employer and considers qualified applicants for employment without regard to race, colour, creed, religion, national origin, sex, sexual orientation, gender identity and expression, marital or civil partnership status, pregnancy, age, disability, veteran status or any other protected factor under federal, state or local law.